fumarates and Foot-Diseases

fumarates has been researched along with Foot-Diseases* in 2 studies

Other Studies

2 other study(ies) available for fumarates and Foot-Diseases

ArticleYear
Dimethyl fumarate contact dermatitis of the foot: an increasingly widespread disease.
    International journal of dermatology, 2012, Volume: 51, Issue:1

    Dimethyl fumarate (DMF) has been recognized as an extremely potent irritant and sensitizer found in sachets inside furniture. The first skin manifestations were correlated to contact with sofas, chairs, and other furniture. In these last years, some papers have reported a development of allergic contact dermatitis on the foot caused by DMF present in high concentration in shoes made in China.. We report the case of a 37-year-old woman who presented with severe eczema on the foot shortly after having bought a new pair of shoes. The diagnosis was performed by patch tests with DMF in several dilutions, with pieces of internal and external parts of the shoes, and by chemical analysis of the shoes.. In the last three years, goods containing DMF increased diffusely despite the augmentation on global preventive measures by Europe.. Therefore, new cases of contact dermatitis could be dependent on DMF, and it is of note that this allergen is not included in most series for patch testing.

    Topics: Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Dermatitis, Contact; Dermatologic Agents; Dimethyl Fumarate; Female; Foot Diseases; Fumarates; Humans; Patch Tests; Shoes

2012
A case of contact dermatitis to dimethylfumarate in shoes identified in Italy.
    Annali dell'Istituto superiore di sanita, 2010, Volume: 46, Issue:4

    The present paper describes a case of shoe contact dermatitis from DMF identified by the Poison Control Centre of Milan (PCCM), Italy, in 2009. A 35 year old woman was affected by irritant reactions while wearing shoes contaminated with DMF. Exposure to these shoes was limited to a 8 hour period and was not repeated. In the following days the patient suffered feet blistering and swelling limited to the area in contact with shoe vamp. Topical application of cortisone did not prevent development of bullous eczema. After 20 days from exposure, the lesions were healed but the skin remained red, dry and very sensitive. Chemical analyses of shoes quantified an average concentration of DMF of 383 mg/kg. The patient refused to be patch tested. The observation here reported confirm that DMF should be considered a possible causal agent in shoe contact dermatitis. Documentation of cases exposed to this chemical provide a relevant support to characterize clinical manifestations and to identifying contaminated articles.

    Topics: Adult; Dermatitis, Contact; Dermatologic Agents; Dimethyl Fumarate; Female; Foot Diseases; Fumarates; Humans; Italy; Shoes; Skin Tests

2010